SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-115418
Filing Date
2024-11-07
Accepted
2024-11-07 18:57:21
Documents
1
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2427856-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2427856-2_4seq1.xml 4 3552
  Complete submission text file 0001104659-24-115418.txt   4998
Mailing Address C/O CURAGEN CORP 555 LONG WHARF DR. 11TH FL. NEW HAVEN CT 06511
Business Address
EBSWORTH DAVID R (Reporting) CIK: 0001207107 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38067 | Film No.: 241437558

Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Issuer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)